Liquefied Natural Gas Market: Global Industry Research Report 2020-2027 | Envisage Research

Liquefied Natural Gas Market - By Technology (Wind Turbine, Solar Photovoltaic, Reciprocating Engines, Others) By Applications (Transportation Fuel, Power Generation, Others) By Region (North America, Europe, Asia Pacific, Central & South America, Middle East & Africa) - Industry Analysis, Opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 181

Status: Published

Report Code: EMR100620

The global liquefied natural gas market demand was 370.06 million in 2020 and is expected to grow at USD 550.6 million by 2027 at a compound annual growth rate (CAGR) of 5.9% from 2021 to 2027. Rapid growth in pipeline infrastructures with favorable government regulations, rising demand for natural gas (NG) from downstream industries, and fluctuation in oil prices are some of the major factors fueling the industry growth. Growing focus on the expansion of adequate support for infrastructure across the developing as well as developed nations is estimated to propel the liquefied natural gas (LNG) demand over the forecast period. However, inadequate pipeline infrastructure in remote locations is likely to hinder the market growth. Growing industrialization and urbanization, along with a growing number of power-related projects, such as petrochemicals and city gas distribution (CGD), are expected to subsidize expressively towards the market growth in the upcoming years.

New infrastructure and production projects are expected to come online within growth trends that are obviously below earlier LNG prospects, supporting the prospects of low prices and overcapacity. This casts a tracker over future finances, which will be needed in the long-term basis to guarantee the renewal of production and security of supply throughout the region.

The United States NG industry has vividly transformed over the last 10 years with half prices as production grew by nearly 50%. The significant driver to the current energy resurgence is the largely surprisingly success on extraction unconventional gas, most especially in the Utica and Marcellus shale plays in Appalachia with an ability of Eastern part of Canada to receive more imports from the United States and throughput at the Cove Point liquefied natural gas export facility located at Maryland. Hence, for the U.S. to sustainably build a new liquefied natural gas export industry, producers will need to produce gas at low prices not only by financing additional capital to explore and drill more wells but also by pursuing new technologies and leveraging operational efficiencies, which will drive the LNG market.
Some of the major drivers of future supply growth for LNG are the United States shale and large conventional projects across Russia and the Middle East, which are also under pressure from the recent decline in oil prices, and ambiguity surrounding demand trends over the medium and short term. The surge in investment in liquefied natural gas projects throughout 2018 and 2019 brought export capacity in North America, Russia, and Africa. Slower growth in worldwide gas demand in the upcoming years is expected to result in capacity outperforming LNG imports in the future and mitigating the risk of a tight liquefied natural gas market for the time being.

As the traditional market has somewhat challenged the liquefied natural gas suppliers who are energetically following 2nd tier market, those with limited or intermittent year-round demand and fewer robust balance sheets. With an upsurge in trading within Southeast Asia, the Caribbean, and the Middle East, these regions are expanding their market for liquefied natural gas and providing chances for small-scale expansions on the supplier side.

For 2020, 1st quarter has demonstrated to be challenging for LNG and natural gas producers as last year, the low price of gas has prevailed through the fourth quarter. The rise in liquefied natural gas exports in the areas of the Northern Hemisphere led to a drop in worldwide gas prices. The bearish attitude continued during February and March as markets across the globe started to declare country lockdowns in order to control the spreading of the virus.

Key players are Total, Chevron Corporation, Exxon Mobil Corporation, Petronet LNG Limited, China National Petroleum Corporation, Petroliam NasionalBerhad (PETRONAS), Snam SPA, PetroChina Company Limited, Royal Dutch Shell, BP, Equinor ASA, Gazprom, China Petroleum & Chemical Corporation, EniSpA, ConocoPhillips Company.

Analyst Commentary

Based on the application type, the market is segregated as a transportation fuel, power generation, and others. The power generation application segment accounted for the largest volume share of 47.1% in 2019. The growth of the transportation fuel segment is ascribed to the growing use of liquefied natural gas as fuel in vehicles across European countries and China. The liquefied natural gas fuel vehicle system carries NG to the engine at a required supply pressure while maximizing the fuel density of the fueling and tanks stations. These aspects are expected to fuel demand during the projected period.

As liquefied natural gas continues to play a vibrant role in the power generation, mining, and industrial sectors with NG usage as a vital feedstock for generating power across various industries, an enormous impact on switching fuel to liquefied natural gas fuel is expected to affect the emissions produced by the transportation sector.

Growing demand for NG is highly useful for the environment owing to the reduced amount of harmful environmental impacts. Increased usage of this fuel in the mining, industrial and power generation sectors has displayed a significant change over the historic period. A decline in the prices, as well as low fuel switching costs, is enhancing the industry growth in the transportation and power generation application.

India, Brazil, Japan, and China are likely to witness peak demand owing to rapidly growing investments in LNG infrastructure development and increasing awareness regarding the excellent benefits of eco-friendly products across diverse end-use industries. Favorable regulations in these markets have also attracted incredible investments from foreign companies and other investors.

Segmentation

The Liquefied Natural Gas segmented on the basis of Technology, Application and region. On the basis of Technology Wind Turbine, Solar Photovoltaic, Reciprocating Engines, Fuel Cells, Gas & Steam Turbine. On the basis of Application Residential, Commercial & Industrial.

Regional Analysis

The Asia Pacific region accounted for the largest revenue share of 41.3% in 2019. Australia is one of the global exporters of liquefied natural gas, with major projects in Queensland and Western Australia. Moreover, at times, these projects have faced planning pressure and significant cost, making them a challenge for the operators and developers owing to the drastic decrease in LNG prices.
Increasing demand from nuclear plants in Eastern Asia is likely to impact the energy mix of South Korea and Japan. India is expected to remain an attractive location for the exporters and manufacturers owing to the upsurge in the infrastructure development. Approximately over 30% of new LNG supply capacity is under construction and is expected to come online by 2025.

The European Union has increased its dependence on gas imports and with producers in the U.S., is pursuing an overseas market for LNG and pipeline infrastructure. Russia is one of the major exporters and a dominant player of the LNG market as one of its companies is capable of exporting fuel from its remote locations to other countries using pipeline infrastructure and other means of transportation.
In 2019, globally LNG import grew over 12% during the first nine months. Where China’s LNG import increased by 14-16% in 2019. Numerous other countries such as Mexico, Egypt, and China are moving forward with significant restructurings by inviting more private partnerships in the supply, marketing, transportation chain, and familiarizing with 3rd-party access to LNG infrastructure.

India is projected to register the highest growth rate in the Asia Pacific in the coming years. Energy mix gas accounts for only 4-5% of prime energy consumption across the country, letting ample space for development. Robust economic growth across the country is also leading towards higher consumption of gas-based power facilities with an enhanced application scope for the market. These factors are hence expected to boost the demand for liquefied natural gas across the market.

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Vitamin D Therapy Market
Chapter 5. Global Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
5.1. Global Vitamin D Therapy Market Share, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
5.1.1. Oral
5.1.1.1. Market Type and Projections,2015 - 2027 (Kiloton) (USD Million)
5.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
5.1.2. Parental
5.1.2.1. Market Type and Projections,2015 - 2027 (Kiloton) (USD Million)
5.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
Chapter 6. Global Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(Kiloton) (USD Million)
6.1. Global Vitamin D Therapy Market Share, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
6.1.1. Prescription Drugs
6.1.1.1. Market Type and Projections,2015 - 2027 (Kiloton) (USD Million)
6.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
6.1.2. Over-the-counter Drugs
6.1.2.1. Market Type and Projections, 2015 - 2027 (Kiloton) (USD Million)
6.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
Chapter 7. Global Vitamin D Therapy Market Overview, By Age group, 2015 - 2027(Kiloton) (USD Million)
7.1. Global Vitamin D Therapy Market Share, By Age group, 2015 - 2027 (Kiloton) (USD Million)
7.1.1. Children
7.1.1.1. Market Type and Projections,2015 - 2027 (Kiloton) (USD Million)
7.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
7.1.2. Adults
7.1.2.1. Market Type and Projections, 2015 - 2027 (Kiloton) (USD Million)
7.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
7.1.3. Senior Adults
7.1.3.1. Market Type and Projections, 2015 - 2027 (Kiloton) (USD Million)
7.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
Chapter 8. Global Vitamin D Therapy Market Overview, By Application, 2015 - 2027(Kiloton) (USD Million)
8.1. Global Vitamin D Therapy Market Share, By Application, 2015 - 2027 (Kiloton) (USD Million)
8.1.1. Osteoporosis
8.1.1.1. Market Type and Projections,2015 - 2027 (Kiloton) (USD Million)
8.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
8.1.2. Rickets
8.1.2.1. Market Type and Projections, 2015 - 2027 (Kiloton) (USD Million)
8.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
8.1.3. Muscle weakness
8.1.3.1. Market Type and Projections, 2015 - 2027 (Kiloton) (USD Million)
8.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
8.1.4. Autoimmune disorders
8.1.4.1. Market Type and Projections, 2015 - 2027 (Kiloton) (USD Million)
8.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
8.1.5. Skin diseases
8.1.5.1. Market Type and Projections, 2015 - 2027 (Kiloton) (USD Million)
8.1.5.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
8.1.6. Others
8.1.6.1. Market Type and Projections, 2015 - 2027 (Kiloton) (USD Million)
8.1.6.2. Market Type and Projections, by Region, 2015 - 2027 (Kiloton) (USD Million)
Chapter 9. Global Vitamin D Therapy Market Overview, By Geography, 2015 - 2027(Kiloton) (USD Million)
9.1. Global Vitamin D Therapy Market Share, By Geography, 2015 - 2027(Kiloton) (USD Million)
9.1.1. Market Type and projections, by Countries, 2015 - 2027 (Kiloton) (USD Million)
9.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 10. North America Vitamin D Therapy Market Overview, By Countries, 2015 - 2027(Kiloton) (USD Million)
10.1. North America Vitamin D Therapy Market Overview, 2015 - 2027 (Kiloton) (USD Million)
10.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
10.1.2. North America Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
10.1.3. North America Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
10.1.4. North America Vitamin D Therapy Market Overview, By Age group,2015 - 2027 (Kiloton) (USD Million)
10.1.5. North America Vitamin D Therapy Market Overview, By Application,2015 - 2027 (Kiloton) (USD Million)
10.1.6. North America Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.1. U.S. Vitamin D Therapy Market Overview, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.1.2. U.S. Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.1.3. U.S. Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.1.4. Other Segment
10.1.6.2. Canada Vitamin D Therapy Market Overview, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.2.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.2.2. Canada Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.2.3. Canada Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.2.4. Other Segment
10.1.6.3. Mexico Vitamin D Therapy Market Overview, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.3.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.3.2. Mexico Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.3.3. Mexico Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
10.1.6.3.4. Other Segment
Chapter 11. Europe Vitamin D Therapy Market Overview, By Countries, 2015 - 2027(Kiloton) (USD Million)
11.1. Europe Vitamin D Therapy Market Overview, 2015 - 2027 (Kiloton) (USD Million)
11.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
11.1.2. Europe Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
11.1.3. Europe Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
11.1.4. Europe Vitamin D Therapy Market Overview, By Age group,2015 - 2027 (Kiloton) (USD Million)
11.1.5. Europe Vitamin D Therapy Market Overview, By Application,2015 - 2027 (Kiloton) (USD Million)
11.1.6. Europe Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (Kiloton) (USD Million)
11.1.6.1. Germany
11.1.6.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
11.1.6.1.2. Germany Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
11.1.6.1.3. Germany Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(Kiloton) (USD Million)
11.1.6.1.4. Other Segments
11.1.6.2. France
11.1.6.2.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
11.1.6.2.2. France Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
11.1.6.2.3. France Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(Kiloton) (USD Million)
11.1.6.2.4. Other Segments
11.1.6.3. UK
11.1.6.3.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
11.1.6.3.2. UK Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
11.1.6.3.3. UK Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(Kiloton) (USD Million)
11.1.6.3.4. Other Segments
11.1.6.4. Italy
11.1.6.4.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
11.1.6.4.2. Italy Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
11.1.6.4.3. Italy Vitamin D Therapy Market Overview, By Purchasing Pattern2015 - 2027(Kiloton) (USD Million)
11.1.6.4.4. Other Segments
11.1.6.5. Spain
11.1.6.5.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
11.1.6.5.2. Spain Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
11.1.6.5.3. Spain Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(Kiloton) (USD Million)
11.1.6.5.4. Other Segments
11.1.6.6. Rest of Europe
11.1.6.6.1. Market Type and projections, 2015 – 2027
11.1.6.6.2. Rest of Europe Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
11.1.6.6.3. Rest of Europe Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(Kiloton) (USD Million)
11.1.6.6.4. Other Segments
Chapter 12. Asia Pacific Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (Kiloton) (USD Million)
12.1. Asia Pacific Vitamin D Therapy Market Overview, 2015 - 2027 (Kiloton) (USD Million)
12.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
12.1.2. Asia Pacific Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
12.1.3. Asia Pacific Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
12.1.4. Asia Pacific Vitamin D Therapy Market Overview, By Age group,2015 - 2027 (Kiloton) (USD Million)
12.1.5. Asia Pacific Vitamin D Therapy Market Overview, By Application,2015 - 2027 (Kiloton) (USD Million)
12.1.6. Asia Pacific Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (Kiloton) (USD Million)
12.1.6.1. India
12.1.6.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
12.1.6.1.2. India Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
12.1.6.1.3. India Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
12.1.6.1.4. Other Segments
12.1.6.2. China
12.1.6.2.1. Market Type and projections, 2015 - 2027(Kiloton) (USD Million)
12.1.6.2.2. China Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
12.1.6.2.3. China Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
12.1.6.2.4. Other Segments
12.1.6.3. Japan
12.1.6.3.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
12.1.6.3.2. Japan Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
12.1.6.3.3. Japan Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027(Kiloton) (USD Million)
12.1.6.3.4. Other Segments
12.1.6.4. South Korea
12.1.6.4.1. Market Type and projections, 2015 - 2027(Kiloton) (USD Million)
12.1.6.4.2. South Korea Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
12.1.6.4.3. South Korea Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
12.1.6.4.4. Other Segments
12.1.6.5. Rest of Asia Pacific
12.1.6.5.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
12.1.6.5.2. Rest of Asia Pacific Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027(Kiloton) (USD Million)
12.1.6.5.3. Rest of Asia Pacific Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
12.1.6.5.4. Other Segments
Chapter 13. Middle East & Africa Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (Kiloton) (USD Million)
13.1. Middle East & Africa Vitamin D Therapy Market Overview, 2015 - 2027 (Kiloton) (USD Million)
13.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
13.1.2. Middle East & Africa Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
13.1.3. Middle East & Africa Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
13.1.4. Middle East & Africa Vitamin D Therapy Market Overview, By Age group,2015 - 2027 (Kiloton) (USD Million)
13.1.5. Middle East & Africa Vitamin D Therapy Market Overview, By Application,2015 - 2027 (Kiloton) (USD Million)
13.1.6. Middle East & Africa Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.1. GCC
13.1.6.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.1.2. GCC Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.1.3. GCC Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.1.4. Other Segments
13.1.6.2. South Africa
13.1.6.2.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.2.2. South Africa Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.2.3. South Africa Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.2.4. Other Segments
13.1.6.3. Rest of Middle East & Africa
13.1.6.3.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.3.2. Rest of Middle East & Africa Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.3.3. Rest of Middle East & Africa Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
13.1.6.3.4. Other Segments
Chapter 14. South America Vitamin D Therapy Market Overview, By Countries, 2015 - 2027 (Kiloton) (USD Million)
14.1. South America Vitamin D Therapy Market Overview, 2015 - 2027 (Kiloton) (USD Million)
14.1.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
14.1.2. South America Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
14.1.3. South America Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
14.1.4. South America Vitamin D Therapy Market Overview, By Age group,2015 - 2027 (Kiloton) (USD Million)
14.1.5. South America Vitamin D Therapy Market Overview, By Application,2015 - 2027 (Kiloton) (USD Million)
14.1.6. South America Vitamin D Therapy Market Overview, By Countries, 2015- 2026 (Kiloton) (USD Million)
14.1.7. Brazil
14.1.7.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
14.1.7.2. Brazil Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
14.1.7.3. Brazil Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
14.1.7.4. Other Segments
14.1.8. Argentina
14.1.8.1. Market Type and projections, 2015 - 2027 (Kiloton) (USD Million)
14.1.8.2. Argentina Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
14.1.8.3. Argentina Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
14.1.8.4. Other Segments
14.1.9. Rest of South America
14.1.9.1. Market Type and projections, 2015 – 2027
14.1.9.2. Rest of South America Vitamin D Therapy Market Overview, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
14.1.9.3. Rest of South America Vitamin D Therapy Market Overview, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
14.1.9.4. Other Segments
Chapter 15. Competitive Landscape
15.1. Competitive environment, 2020
15.2. Strategic framework
15.2.1. Partnership/agreement
15.2.2. Expansion
15.2.3. Mergers & Acquisitions
15.2.4. New Technology development
Chapter 16. Key Vendor Analysis
16.1. Sanofi
16.1.1. Company overview
16.1.2. Financial performance
16.1.3. Mice Benchmarking
16.1.4. Recent initiatives
16.1.5. SWOT analysis
16.2. GlaxoSmithKline plc
16.2.1. Company overview
16.2.2. Financial performance
16.2.3. Mice Benchmarking
16.2.4. Recent initiatives
16.2.5. SWOT analysis
16.3. Pfizer Inc
16.3.1. Company overview
16.3.2. Financial performance
16.3.3. Mice Benchmarking
16.3.4. Recent initiatives
16.4. Merck & Co., Inc
16.5. Torrent Pharmaceuticals
16.6. Novartis International AG
16.7. Alkem Laboratories
16.8. Sun Pharmaceuticals Industries Ltd.
16.9. Cadila Healthcare Ltd.
16.10. Others
Chapter 17. Vitamin D Therapy Market Cost Analysis
17.1. Vitamin D Therapy Market Key Technology Analysis
17.1.1. Key Technology
17.1.2. Price Trend of Key Technology
17.1.3. Key Suppliers of Technology
17.1.4. Market Concentration Rate of Technology
17.1.5. Technology
17.1.6. Labor Cost
Chapter 18. Industrial Chain, Sourcing Strategy and Downstream Buyers
18.1. Vitamin D Therapy Market Industrial Chain Analysis
18.2. Upstream Technology Sourcing
18.3. Technology Sources of Vitamin D Therapy Market Major Manufacturers in 2021
18.4. Downstream Buyers
Chapter 19. Marketing Strategy Analysis, Distributors/Traders
19.1. Marketing Channel
19.1.1. Direct Marketing
19.1.2. Indirect Marketing
19.1.3. Marketing Channel Development Trend
19.2. Market Positioning
19.2.1. Pricing Strategy
19.2.2. Brand Strategy
19.2.3. Target Client
19.3. Distributors/Traders List
Chapter 20. Market Effect Factors Analysis
20.1. Technology Progress/Risk
20.1.1. Substitutes Threat
20.1.2. Technology Progress in Related Type
20.2. Consumer Needs/Customer Preference Change
20.3. Economic/Political Environmental Change
Chapter 21. Future Outlook of the Market
Disclaimer 
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Vitamin D Therapy Market share, By Route of Administration, 2020 & 2027 (%)
10. Global Vitamin D Therapy Market share, by Oral, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
11. Global Vitamin D Therapy Market share, by Parental, By Route of Administration, 2015 - 2027 (Kiloton) (USD Million)
12. Global Vitamin D Therapy Market share, By Purchasing Pattern, 2020 & 2027 (%)
13. Global Vitamin D Therapy Market share, by Prescription Drugs, By Purchasing Pattern, 2015 - 2027 (Kiloton) (USD Million)
14. Global Vitamin D Therapy Market share, by Over-the-counter Drugs, By Purchasing Pattern 2015 - 2027 (Kiloton) (USD Million)
15. Global Vitamin D Therapy Market share, By Age group, 2020 & 2027 (%)
16. Global Vitamin D Therapy Market share, by Children, By Age group, 2015 - 2027 (Kiloton) (USD Million)
17. Global Vitamin D Therapy Market share, by Adults, By Age group 2015 - 2027 (Kiloton) (USD Million)
18. Global Vitamin D Therapy Market share, by Senior Adults, By Age group 2015 - 2027 (Kiloton) (USD Million)
19. Global Vitamin D Therapy Market Overview, By Application, 2020 & 2027 (%)
20. Global Vitamin D Therapy Market share, by Osteoporosis, By Application 2015 - 2027 (Kiloton) (USD Million)
21. Global Vitamin D Therapy Market share, by Rickets, By Application 2015 - 2027 (Kiloton) (USD Million)
22. Global Vitamin D Therapy Market share, by Muscle weakness, By Application 2015 - 2027 (Kiloton) (USD Million)
23. Global Vitamin D Therapy Market share, by Autoimmune disorders, By Application 2015 - 2027 (Kiloton) (USD Million)
24. Global Vitamin D Therapy Market share, by Skin diseases, By Application 2015 - 2027 (Kiloton) (USD Million)
25. Global Vitamin D Therapy Market share, by Others, By Application 2015 - 2027 (Kiloton) (USD Million)
26. Global Vitamin D Therapy Market share, by region, 2020 & 2027 (%)
27. Global Vitamin D Therapy Market share, by region, 2015 - 2027(Kiloton) (USD Million)
28. North America Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
29. North America Vitamin D Therapy Market share, by Countries, 2020 & 2027 (%)
30. U.S. Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
31. Canada Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
32. Mexico Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
33. Europe Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
34. Europe Vitamin D Therapy Market share, by Countries, 2020 & 2027 (%)
35. Spain Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
36. UK Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
37. Italy Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
38. Germany Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
39. France Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
40. Rest of Europe Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
41. Asia-Pacific Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
42. Asia-Pacific Vitamin D Therapy Market share, by Countries, 2020 & 2027 (%)
43. China Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
44. India Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
45. Australia Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
46. Japan Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
47. Rest of Asia-Pacific Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
48. Middle East & Africa Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
49. Middle East & Africa Vitamin D Therapy Market share, by Countries, 2020 & 2027 (%)
50. GCC Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
51. South Africa Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
52. Rest Of Middle East & Africa Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
53. South America Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
54. Brazil Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
55. Mexico Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
56. Argentina Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)
57. Rest Of South America Vitamin D Therapy Market, 2015 - 2027(Kiloton) (USD Million)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Vitamin D Therapy Market, 2015-2027 (Kiloton) (USD Million)
4. Vitamin D Therapy requirement, by country, 2015-2027, (Kiloton) (USD Million)
5. North America Vitamin D Therapy Market, By Route of Administration, 2015-2027 (Kiloton) (USD Million)
6. North America Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (Kiloton) (USD Million)
7. North America Vitamin D Therapy Market, By Age group, 2015-2027 (Kiloton) (USD Million)
8. North America Vitamin D Therapy Market, By Application, 2015-2027 (Kiloton) (USD Million)
9. Europe Vitamin D Therapy Market, By Route of Administration, 2015-2027 (Kiloton) (USD Million)
10. Europe Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (Kiloton) (USD Million)
11. Europe Vitamin D Therapy Market, By Age group, 2015-2027 (Kiloton) (USD Million)
12. Europe Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (Kiloton) (USD Million)
13. Europe Vitamin D Therapy Market, By Application, 2015-2027 (Kiloton) (USD Million)
14. Asia Pacific Vitamin D Therapy Market, By Route of Administration, 2015-2027 (Kiloton) (USD Million)
15. Asia Pacific Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (Revenue, USD Million)
16. Asia Pacific Vitamin D Therapy Market, By Age group, 2015-2027 (Revenue, USD Million)
17. Asia Pacific Vitamin D Therapy Market, By Application, 2015-2027 (Revenue, USD Million)
18. Middle East & Africa Vitamin D Therapy Market, By Route of Administration, 2015-2027 (Kiloton) (USD Million)
19. Middle East & Africa Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (Kiloton) (USD Million)
20. Middle East & Africa Vitamin D Therapy Market, By Age group, 2015-2027 (Kiloton) (USD Million)
21. Middle East & Africa Vitamin D Therapy Market, By Application, 2015-2027 (Kiloton) (USD Million)
22. South America Vitamin D Therapy Market, By Route of Administration, 2015-2027 (Kiloton) (USD Million)
23. South America Vitamin D Therapy Market, By Purchasing Pattern, 2015-2027 (Kiloton) (USD Million)
24. South America Vitamin D Therapy Market, By Age group, 2015-2027 (Kiloton) (USD Million)
25. South America Vitamin D Therapy Market, By Application, 2015-2027 (Kiloton) (USD Million)
26. Global Vitamin D Therapy Market, Company Market Share, 2020 - 2027 (%)
27. Sanofi: Product Benchmarking
28. Sanofi: Financial Performance
29. GlaxoSmithKline plc: Product Benchmarking
30. GlaxoSmithKline plc: Financial Performance
31. Pfizer Inc.: Product Benchmarking
32. Pfizer Inc.: Financial Performance
33. Merck & Co., Inc.: Product Benchmarking
34. Merck & Co., Inc.: Financial Performance
35. Torrent Pharmaceuticals: Product Benchmarking
36. Torrent Pharmaceuticals: Financial Performance
37. Novartis International AG: Product Benchmarking
38. Novartis International AG: Financial Performance
39. Alkem Laboratories: Product Benchmarking
40. Alkem Laboratories: Financial Performance
41. Sun Pharmaceuticals Industries Ltd.: Product Benchmarking
42. Sun Pharmaceuticals Industries Ltd.: Financial
43. Cadila Healthcare Ltd.: Product Benchmarking
44. Cadila Healthcare Ltd.: Financial Performance

The Leading Key Players in Liquefied Natural Gas Market

Chevron Corporation
Exxon Mobil Corporation
Petronet LNG Limited
China National Petroleum Corporation
Petroliam NasionalBerhad (PETRONAS)
Snam SPA
PetroChina Company Limited
Royal Dutch Shell
BP
Equinor ASA
Gazprom
China Petroleum & Chemical Corporation
EniSpA
ConocoPhillips Company.